These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 17979841

  • 1. From cancer immunosurveillance to cancer immunotherapy.
    Stagg J, Johnstone RW, Smyth MJ.
    Immunol Rev; 2007 Dec; 220():82-101. PubMed ID: 17979841
    [Abstract] [Full Text] [Related]

  • 2. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
    Peggs KS, Quezada SA, Allison JP.
    Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
    [Abstract] [Full Text] [Related]

  • 3. [Immune response and cancer].
    El Hage F, Abouzahr-Rifai S, Meslin F, Mami-Chouaib F, Chouaib S.
    Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
    [Abstract] [Full Text] [Related]

  • 4. A fresh look at tumor immunosurveillance and immunotherapy.
    Smyth MJ, Godfrey DI, Trapani JA.
    Nat Immunol; 2001 Apr; 2(4):293-9. PubMed ID: 11276199
    [Abstract] [Full Text] [Related]

  • 5. Targeting costimulatory pathways for tumor immunotherapy.
    Ward RC, Kaufman HL.
    Int Rev Immunol; 2007 Apr; 26(3-4):161-96. PubMed ID: 17558743
    [Abstract] [Full Text] [Related]

  • 6. Improving cancer immunotherapy by targeting tumor-induced immune suppression.
    Stewart TJ, Smyth MJ.
    Cancer Metastasis Rev; 2011 Mar; 30(1):125-40. PubMed ID: 21249424
    [Abstract] [Full Text] [Related]

  • 7. Monitoring cellular immune responses to cancer immunotherapy.
    Morse MA, Clay TM, Hobeika AC, Mosca PJ, Lyerly HK.
    Curr Opin Mol Ther; 2001 Feb; 3(1):45-52. PubMed ID: 11249731
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunogenic anti-cancer chemotherapy as an emerging concept.
    Haynes NM, van der Most RG, Lake RA, Smyth MJ.
    Curr Opin Immunol; 2008 Oct; 20(5):545-57. PubMed ID: 18573339
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.
    Berinstein NL.
    Ann N Y Acad Sci; 2009 Sep; 1174():107-17. PubMed ID: 19769743
    [Abstract] [Full Text] [Related]

  • 13. Emerging strategies in regulatory T-cell immunotherapies.
    Gajewski TF, Chesney J, Curriel TJ.
    Clin Adv Hematol Oncol; 2009 Jan; 7(1):1-10; quiz 11-2. PubMed ID: 19288606
    [Abstract] [Full Text] [Related]

  • 14. Targeted therapies to improve tumor immunotherapy.
    Begley J, Ribas A.
    Clin Cancer Res; 2008 Jul 15; 14(14):4385-91. PubMed ID: 18628452
    [Abstract] [Full Text] [Related]

  • 15. Boosting the immune response: an alternative combination therapy for cancer patients.
    Thyphronitis G, Koutsilieris M.
    Anticancer Res; 2004 Jul 15; 24(4):2443-53. PubMed ID: 15330197
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. NK cell-based cancer immunotherapy.
    Stagg J, Smyth MJ.
    Drug News Perspect; 2007 Apr 15; 20(3):155-63. PubMed ID: 17520092
    [Abstract] [Full Text] [Related]

  • 18. Cancer despite immunosurveillance: immunoselection and immunosubversion.
    Zitvogel L, Tesniere A, Kroemer G.
    Nat Rev Immunol; 2006 Oct 15; 6(10):715-27. PubMed ID: 16977338
    [Abstract] [Full Text] [Related]

  • 19. The use of gene transfer in cancer immunotherapy.
    Dranoff G.
    Forum (Genova); 1998 Oct 15; 8(4):357-64. PubMed ID: 9863030
    [Abstract] [Full Text] [Related]

  • 20. The immune system--is it relevant to cancer development, progression and treatment?
    Prestwich RJ, Errington F, Hatfield P, Merrick AE, Ilett EJ, Selby PJ, Melcher AA.
    Clin Oncol (R Coll Radiol); 2008 Mar 15; 20(2):101-12. PubMed ID: 18037277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.